Cytosurge and Lab Automation Network (LAN) enter into a strategic partnership to offer automated cell-based solutions for pharmaceutical and biotech applications.
Cytosurge is the leading technology provider for automated single-cell biology. With its FluidFM BOT, Cytosurge offers automated tools for the injection of drug candidates and nucleic acids into single mammalian cells. Lab Automation Network is an alliance of technologically leading solution providers in the field of laboratory automation. Together with its partners, LAN creates high-performance, integrated, high-quality laboratory automation solutions, tailored to the specific needs of its customers.
"This partnership opens up completely new possibilites to speed up workflows in pharmaceutical drug development and cell line development" says Martin Winter, Managing Director of Lab Automation Network. Alexander Serre, Sales & Marketing Director of Cytosurge, is convinced that joining forces with the other technology leaders in the network "will bring symbiotic win-win solutions for all partners and for our demanding customers".